• Biology, Medicine
  • Published in
    Movement disorders : official…
    2015
  • DOI:10.1002/mds.26319

L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.

@article{Schmitt2015LdopaI,
  title={L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.},
  author={Ina Schmitt and Oliver Kaut and Hassan Khazneh and Laura deBoni and Ashar Ahmad and Daniela Berg and Christine Klein and Holger Fr{\"o}hlich and U W{\"u}llner},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  year={2015},
  volume={30 13},
  pages={
          1794-801
        }
}
BACKGROUND Increasing gene dosages of α-synuclein induce familial Parkinson's disease (PD); thus, the hypothesis has been put forward that regulation of gene expression, in particular altered α-synuclein gene methylation, might be associated with sporadic PD and could be used as a biological marker. METHODS We performed a thorough analysis of α-synuclein methylation in bisulfite-treated DNA from peripheral blood of 490 sporadic PD patients and 485 healthy controls and in addition analyzed the… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics

  • Journal of Parkinson's disease
  • 2016
VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED